1 / 7

Milan, March 4th 2011

ROUND TABLE 2011: AriSLA Survey on ALS research priorities. Milan, March 4th 2011. Priorities in ALS Research & Management . Basic research - neurophysiology and development . Clinical research and management. Basic research - pathogenic mechanisms and etiology.

benard
Download Presentation

Milan, March 4th 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ROUND TABLE 2011: AriSLA Survey on ALS research priorities Milan, March 4th 2011

  2. Priorities in ALS Research & Management Basic research - neurophysiology and development Clinical research and management Basic research - pathogenic mechanisms and etiology Translational research- preclinical testing and disease models Basic and translational research – genes, molecules and biomarkers

  3. Priorities in ALS Research & Management ClinicianvsResearcher 35% 32% 30% 27% 20% 18% 18% 10% 8% 2%

  4. Aspect is currently ignored in ALS research Basic research - neurophysiology and development Clinical research and management Basic research - pathogenic mechanisms and etiology Translational research- preclinical testing and disease models Basic and translational research – genes, molecules and biomarkers

  5. Aspect is currently ignored in ALS research ClinicianvsResearcher 60 % 43% 21 % 21 % 21 % 12 % 7% 7 % 3 % 3 %

  6. Strategic priority of an ALS research funding body Both Funding timely and state-of-art projects based on solid preliminary data Support highly innovative and risky projects

  7. Strategic priority of an ALS research funding body ClinicianvsResearcher 44% 40% 36% 31% 29% 21%

More Related